Chris S.R Hatton

1.4k total citations
21 papers, 855 citations indexed

About

Chris S.R Hatton is a scholar working on Pathology and Forensic Medicine, Oncology and Immunology. According to data from OpenAlex, Chris S.R Hatton has authored 21 papers receiving a total of 855 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pathology and Forensic Medicine, 6 papers in Oncology and 5 papers in Immunology. Recurrent topics in Chris S.R Hatton's work include Lymphoma Diagnosis and Treatment (11 papers), CNS Lymphoma Diagnosis and Treatment (4 papers) and Immunotherapy and Immune Responses (4 papers). Chris S.R Hatton is often cited by papers focused on Lymphoma Diagnosis and Treatment (11 papers), CNS Lymphoma Diagnosis and Treatment (4 papers) and Immunotherapy and Immune Responses (4 papers). Chris S.R Hatton collaborates with scholars based in United Kingdom, Italy and Germany. Chris S.R Hatton's co-authors include Charles R.J. Singer, C Bunch, P.A. Winstanley, Stephen J. Russell, Geoffrey Edwards, Tünde Pető, Geoffrey Pasvol, Andrew Grigg, Michael Lewis and Daniel Wright and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and Blood.

In The Last Decade

Chris S.R Hatton

21 papers receiving 827 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chris S.R Hatton United Kingdom 14 324 234 189 182 180 21 855
U. Fabry Germany 18 302 0.9× 185 0.8× 45 0.2× 93 0.5× 82 0.5× 27 916
JL Harousseau France 19 277 0.9× 675 2.9× 215 1.1× 124 0.7× 113 0.6× 24 1.4k
Dolores Subirá Spain 15 107 0.3× 116 0.5× 201 1.1× 97 0.5× 81 0.5× 40 860
R. C. Ribeiro United States 8 139 0.4× 166 0.7× 61 0.3× 59 0.3× 445 2.5× 17 822
Aristeidis Chaidos United Kingdom 20 165 0.5× 363 1.6× 317 1.7× 51 0.3× 44 0.2× 70 1.4k
A B Skotnicki Poland 14 138 0.4× 146 0.6× 211 1.1× 19 0.1× 122 0.7× 49 585
Hideaki Fujiwara Japan 17 117 0.4× 223 1.0× 75 0.4× 92 0.5× 21 0.1× 71 909
Muhammad Shurafa United States 12 142 0.4× 319 1.4× 262 1.4× 14 0.1× 91 0.5× 29 912
Maria Rita Bongiorno Italy 14 110 0.3× 108 0.5× 32 0.2× 52 0.3× 35 0.2× 70 674
Philipp Haselmayer Germany 13 120 0.4× 106 0.5× 207 1.1× 30 0.2× 44 0.2× 18 847

Countries citing papers authored by Chris S.R Hatton

Since Specialization
Citations

This map shows the geographic impact of Chris S.R Hatton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris S.R Hatton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris S.R Hatton more than expected).

Fields of papers citing papers by Chris S.R Hatton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chris S.R Hatton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris S.R Hatton. The network helps show where Chris S.R Hatton may publish in the future.

Co-authorship network of co-authors of Chris S.R Hatton

This figure shows the co-authorship network connecting the top 25 collaborators of Chris S.R Hatton. A scholar is included among the top collaborators of Chris S.R Hatton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chris S.R Hatton. Chris S.R Hatton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eyre, Toby A., William Wilson, Amy A. Kirkwood, et al.. (2021). Infection-related morbidity and mortality among older patients with DLBCL treated with full- or attenuated-dose R-CHOP. Blood Advances. 5(8). 2229–2236. 19 indexed citations
2.
3.
4.
Ait‐Tahar, Kamel, Martin Barnardo, Graham P. Collins, et al.. (2017). Sp17 Protein Expression and Major Histocompatibility Class I and II Epitope Presentation in Diffuse Large B Cell Lymphoma Patients. Advances in Hematology. 2017. 1–9. 2 indexed citations
5.
Eyre, Toby A., Kim Linton, Jaimal Kothari, et al.. (2016). Results of a multicentre UK‐wide retrospective study evaluating the efficacy of pixantrone in relapsed, refractory diffuse large B cell lymphoma. British Journal of Haematology. 173(6). 896–904. 13 indexed citations
6.
Eyre, Toby A., Kevin C. Gatter, Graham P. Collins, et al.. (2015). Incidence, management, and outcome of high‐grade transformation of nodular lymphocyte predominant hodgkin lymphoma: Long‐term outcomes from a 30‐year experience. American Journal of Hematology. 90(6). E103–10. 24 indexed citations
7.
Collins, Graham P., et al.. (2014). A Phase 2 Trial of AZD1152 in Relapsed/Refractory Diffuse Large B-Cell Lymphoma. Blood. 124(21). 4481–4481. 1 indexed citations
8.
Chen, Hong, Laura Monti, Edith Gould, et al.. (2012). RNASET2 — An autoantigen in anaplastic large cell lymphoma identified by protein array analysis. Journal of Proteomics. 75(17). 5279–5292. 7 indexed citations
9.
Medd, Patrick, Susan H. Turner, Graham P. Collins, et al.. (2011). A novel scoring system combining expression of CD23, CD20, and CD38 with platelet count predicts for the presence of the t(11;14) translocation of mantle cell lymphoma. Cytometry Part B Clinical Cytometry. 80B(4). 230–237. 12 indexed citations
10.
11.
Hatton, Chris S.R, et al.. (2008). Systemic mastocytosis-a case treated with interferon α and radiotherapy. Clinical & Laboratory Haematology. 16(3). 291–294. 2 indexed citations
12.
Liggins, Amanda P., C.D.O. Cooper, Charles H. Lawrie, et al.. (2007). MORC4, a novel member of the MORC family, is highly expressed in a subset of diffuse large B‐cell lymphomas. British Journal of Haematology. 138(4). 479–486. 30 indexed citations
13.
Liggins, Amanda P., Barbara‐ann Guinn, Chris S.R Hatton, Karen Pulford, & Alison H. Banham. (2004). Serologic detection of diffuse large B‐cell lymphoma‐associated antigens. International Journal of Cancer. 110(4). 563–569. 22 indexed citations
14.
Mead, Graham M., Matthew R. Sydes, Jan Walewski, et al.. (2002). An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt’s lymphoma: results of United Kingdom Lymphoma Group LY06 study. Annals of Oncology. 13(8). 1264–1274. 212 indexed citations
15.
Craig, Jamie E., Jacques Rochette, Maurizio Sampietro, et al.. (1997). Genetic heterogeneity in heterocellular hereditary persistence of fetal hemoglobin.. Blood. 90(1). 428–34. 30 indexed citations
16.
Mistry, Pramod K., S. J. Smith, Manir Ali, et al.. (1992). Genetic diagnosis of Gaucher's disease. The Lancet. 339(8798). 889–892. 37 indexed citations
17.
Potter, C. G., Chris S.R Hatton, Helen Chapel, et al.. (1987). Variation of erythroid and myeloid precursors in the marrow and peripheral blood of volunteer subjects infected with human parvovirus (B19).. Journal of Clinical Investigation. 79(5). 1486–1492. 115 indexed citations
18.
Hatton, Chris S.R, C Bunch, Tünde Pető, et al.. (1986). FREQUENCY OF SEVERE NEUTROPENIA ASSOCIATED WITH AMODIAQUINE PROPHYLAXIS AGAINST MALARIA. The Lancet. 327(8478). 411–414. 183 indexed citations
19.
Hatton, Chris S.R, et al.. (1985). Hepatic sequestration in sickle cell anaemia.. BMJ. 290(6470). 744–745. 49 indexed citations
20.
Ghosh, A K, Wendy N. Erber, Chris S.R Hatton, et al.. (1985). Detection of metastatic tumour cells in routine bone marrow smears by immuno‐alkaline phosphatase labelling with monoclonal antibodies. British Journal of Haematology. 61(1). 21–30. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by U. Fabry Breakdown of academic impact, for papers by JL Harousseau Breakdown of academic impact, for papers by Dolores Subirá Breakdown of academic impact, for papers by R. C. Ribeiro Breakdown of academic impact, for papers by Aristeidis Chaidos Breakdown of academic impact, for papers by A B Skotnicki Breakdown of academic impact, for papers by Hideaki Fujiwara Breakdown of academic impact, for papers by Muhammad Shurafa Breakdown of academic impact, for papers by Maria Rita Bongiorno Breakdown of academic impact, for papers by Philipp Haselmayer
Rankless by CCL
2026